Nantahala Capital Management, LLC
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1472322
New Canaan, CT
Position in AMLX
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$8,740,844
+$1,294,837 QoQ
Shares Held
486,684
-9.1% QoQ
Ownership
0.437%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#41
of 207 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Nantahala Capital Management, LLC holds $169,874,929 across 9 Drug Manufacturers - Specialty & Generic names. AMLX ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ETON |
Eton Pharmaceuticals, Inc.
|
1,175,951 | $42,569,426 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
2,268,751 | $39,272,079 | |
| 3 | EOLS |
Evolus, Inc.
|
5,602,021 | $38,878,025 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,901,160 | $19,011,600 | |
| 5 | ADCT |
ADC Therapeutics SA
|
12,326,184 | $13,189,016 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
486,684 | $8,740,844 | |
| 7 | TLPH |
Talphera, Inc.
|
3,492,519 | $3,597,294 | |
| 8 | AYTU |
Aytu Biopharma, Inc
|
1,086,812 | $2,336,645 |
All Filings in AMLX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,740,844 | 486,684 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $7,446,007 | 535,684 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,095,062 | 835,684 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,715,945 | 935,684 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $18,809,536 | 2,934,405 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,387,793 | 2,934,405 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,489,138 | 1,452,153 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,550,787 | 1,404,564 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $9,128,019 | 620,110 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,455,923 | 407,205 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,548,265 | 164,500 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||